Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum
Abstract Background Synapse loss is an early event that precedes neuronal death and symptom onset and is considered the best neuropathological correlate of cognitive decline in Alzheimer’s disease (AD). Vesicle-associated membrane protein 2 (VAMP-2) has emerged as a promising biomarker of AD-related...
Збережено в:
| Автори: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2023-10-01
|
| Серія: | Alzheimer’s Research & Therapy |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s13195-023-01336-0 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|